Fabien CHEVALIER
Equipe : Fonctionnalité et dynamique du tissu cutané
Courriel : fabien.chevalier@ibcp.fr
Téléphone : +33(0)4-72-72-26-74
Statut : Maître de conférences
2016
5. Satellite Cells in Muscular Dystrophy – Lost in Polarity.
Chang Nc, Chevalier Fp, Rudnicki Ma
(2016) Trends Mol Med 22 :479-96 
2015
4. A fine structural modification of glycosaminoglycans is correlated with the progression of muscle regeneration after ischaemia: towards a matrix-based therapy?
Chevalier F, Arnaud D, Henault E, Guillevic O, Sineriz F, Ponsen Ac, Papy-garcia D, Barritault D, Letourneur D, Uzan G, Meddahi-pelle A, Hlawaty H, Albanese P
(2015) Eur Cell Mater 30 :51-68
3. Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.
Haddad O, Guyot E, Marinval N, Chevalier F, Maillard L, Gadi L, Laguillier-morizot C, Oudar O, Sutton A, Charnaux N, Hlawaty H
(2015) Mar Drugs 13 :6588-608
2014
2. Glycosaminoglycan mimetic improves enrichment and cell functions of human endothelial progenitor cell colonies.
Chevalier F, Lavergne M, Negroni E, Ferratge S, Carpentier G, Gilbert-sirieix M, Sineriz F, Uzan G, Albanese P
(2014) Stem Cell Res 12 :703-15
1. Glycosaminoglycan modifications in Duchenne muscular dystrophy: specific remodeling of chondroitin sulfate/dermatan sulfate.
Negroni E, Henault E, Chevalier F, Gilbert-sirieix M, Van Kuppevelt Th, Papy-garcia D, Uzan G, Albanese P
(2014) J Neuropathol Exp Neurol 73 :789-97
